Management of acute<unk>  involves providing a patient with respiratory support and intravenous deferoxamine. Patients exhibiting severe symptoms in the gastrointestinal phase should receive volume resuscitation to prevent hypovolemic shock from the loss of blood volume. Normal saline is administered intravenously to maintain adequate volume of fluid in the body. Deferoxamine is a drug that is used in cases of serious<unk> . It is a chelating agent and binds to free<unk>  in the body in order to be eliminated by the kidneys into urine. Dosing of deferoxamine should be determined through consultation with a toxicologist but is typically continuously infused at 15 mg/kg to 35 mg/kg per hour and not exceeding the maximum daily dose of 6 grams for adults. In pediatric patients, doses should not exceed 15 mg/kg per hour. recommended duration of treatment is until symptoms have resolved which is usually 24 hours. In non-fatal cases of<unk>  where there is liver failure, liver transplantation may be necessary. Treatment of<unk>  should be based on clinical presentation, peak serum<unk>  levels and other laboratory results. As a general guideline, patients who have ingested lower doses of elemental<unk> , have a peak serum<unk>  level less than 500mcg/dL and are asymptomatic or only exhibit mild gastrointestinal symptoms typically do not require treatment and should be monitored for 6 hours after ingestion. In cases where high doses of elemental<unk>  have been ingested and the patient is exhibiting signs and symptoms of severe systemic<unk> , supportive care measures like volume resuscitation and deferoxamine should be initiated immediately. A quick response to<unk>  can significantly improve clinical outcomes.
Iron poisoning
Zinc toxicity
Mercury poisoning
Lead poisoning
Cobalt poisoning
Cadmium poisoning
Salt poisoning
Mercury Poisoning